BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 27025360)

  • 21. A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients.
    Messerschmidt GL; Makuch R; Appelbaum F; Ungerleider RS; Abrams R; O'Donnell J; Holohan TV; Fontana J; Wright D; Anagnou NP
    Cancer; 1988 Aug; 62(4):795-801. PubMed ID: 3293762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 x 10(9) or 20 x 10(9) per L.
    Nevo S; Fuller AK; Zahurak ML; Hartley E; Borinsky ME; Vogelsang GB
    Transfusion; 2007 Sep; 47(9):1700-9. PubMed ID: 17725737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neonatal Platelet Transfusions and Future Areas of Research.
    Sola-Visner M; Bercovitz RS
    Transfus Med Rev; 2016 Oct; 30(4):183-8. PubMed ID: 27282660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial.
    Lye DC; Archuleta S; Syed-Omar SF; Low JG; Oh HM; Wei Y; Fisher D; Ponnampalavanar SSL; Wijaya L; Lee LK; Ooi EE; Kamarulzaman A; Lum LC; Tambyah PA; Leo YS
    Lancet; 2017 Apr; 389(10079):1611-1618. PubMed ID: 28283286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fecal blood loss: A quantitative method of evaluating hemostasis in patients with thrombocytopenia.
    Slichter SJ; Gernsheimer T; LeBlanc R; Townsend-McCall D; Jones MK; Cuaron L; Bolgiano D
    Transfusion; 2021 Feb; 61(2):393-403. PubMed ID: 33166412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect and duration of prophylactic platelet transfusions before insertion of a central venous catheter in patients with bone marrow failure evaluated with point-of-care methods and flow cytometry.
    Kander T; Tanaka KA; Norström E; Persson J; Schött U
    Anesth Analg; 2014 Oct; 119(4):882-890. PubMed ID: 24854870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia.
    Josephson CD; Granger S; Assmann SF; Castillejo MI; Strauss RG; Slichter SJ; Steiner ME; Journeycake JM; Thornburg CD; Bussel J; Grabowski EF; Neufeld EJ; Savage W; Sloan SR
    Blood; 2012 Jul; 120(4):748-60. PubMed ID: 22538854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lowering the prophylactic platelet transfusion threshold: a prospective analysis.
    Lawrence JB; Yomtovian RA; Hammons T; Masarik SR; Chongkolwatana V; Creger RJ; Manka A; Lazarus HM
    Leuk Lymphoma; 2001 Mar; 41(1-2):67-76. PubMed ID: 11342358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized Trial of Platelet-Transfusion Thresholds in Neonates.
    Curley A; Stanworth SJ; Willoughby K; Fustolo-Gunnink SF; Venkatesh V; Hudson C; Deary A; Hodge R; Hopkins V; Lopez Santamaria B; Mora A; Llewelyn C; D'Amore A; Khan R; Onland W; Lopriore E; Fijnvandraat K; New H; Clarke P; Watts T;
    N Engl J Med; 2019 Jan; 380(3):242-251. PubMed ID: 30387697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Bleeding Risk Index: a clinical prediction rule to guide the prophylactic use of platelet transfusions in patients with lymphoma or solid tumors.
    Elting LS; Martin CG; Kurtin DJ; Cantor SB; Rubenstein EB; Rodriguez S; Kanesan K; Vadhan-Raj S; Benjamin RS
    Cancer; 2002 Jun; 94(12):3252-62. PubMed ID: 12115358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An overview of platelet indices and methods for evaluating platelet function in thrombocytopenic patients.
    Vinholt PJ; Hvas AM; Nybo M
    Eur J Haematol; 2014; 92(5):367-76. PubMed ID: 24400878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. International Study of the Epidemiology of Platelet Transfusions in Critically Ill Children With an Underlying Oncologic Diagnosis.
    Nellis ME; Goel R; Karam O; Cushing MM; Davis PJ; Steiner ME; Tucci M; Stanworth SJ; Spinella PC;
    Pediatr Crit Care Med; 2019 Jul; 20(7):e342-e351. PubMed ID: 31107379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic platelet transfusion and risk of bleeding associated with ultrasound-guided central venous access in patients with severe thrombocytopenia.
    Zarama V; Revelo-Noguera J; Quintero JA; Manzano R; Uribe-Buriticá FL; Carvajal DF; Ochoa LM; Valencia-Orozco A; Sánchez ÁI; Ospina-Tascón GA
    Acad Emerg Med; 2023 Jun; 30(6):644-652. PubMed ID: 36587310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet Transfusion Practices in the ICU: Data From a Large Transfusion Registry.
    Ning S; Barty R; Liu Y; Heddle NM; Rochwerg B; Arnold DM
    Chest; 2016 Sep; 150(3):516-23. PubMed ID: 27102183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Preoperative Platelet Count on Bleeding Risk and Allogeneic Transfusion in Multilevel Spine Surgery.
    Chow JH; Chancer Z; Mazzeffi MA; McNeil JS; Sokolow MJ; Gaines TM; Reif MM; Trinh AT; Wellington IJ; Camacho JE; Bruckner JJ; Tanaka KA; Ludwig S
    Spine (Phila Pa 1976); 2021 Jan; 46(1):E65-E72. PubMed ID: 33306659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation.
    Wandt H; Schaefer-Eckart K; Frank M; Birkmann J; Wilhelm M
    Bone Marrow Transplant; 2006 Feb; 37(4):387-92. PubMed ID: 16400342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan Africa.
    Ddungu H; Krantz EM; Kajja I; Naluzze S; Nabbanja H; Nalubwama F; Phipps W; Orem J; Kiwanuka N; Wald A
    PLoS One; 2019; 14(2):e0211648. PubMed ID: 30726290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The management and outcomes of patients with myelodysplastic syndrome with persistent severe thrombocytopenia: An observational single centre registry study.
    Vijenthira A; Premkumar D; Callum J; Lin Y; Wells RA; Chodirker L; Lenis M; Mamedov A; Buckstein R
    Leuk Res; 2019 Jan; 76():76-81. PubMed ID: 30580105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia.
    Gmür J; Burger J; Schanz U; Fehr J; Schaffner A
    Lancet; 1991 Nov; 338(8777):1223-6. PubMed ID: 1682642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombocytopenia and platelet transfusions in ICU patients: an international inception cohort study (PLOT-ICU).
    Anthon CT; Pène F; Perner A; Azoulay E; Puxty K; Van De Louw A; Barratt-Due A; Chawla S; Castro P; Póvoa P; Coelho L; Metaxa V; Kochanek M; Liebregts T; Kander T; Hästbacka J; Andreasen JB; Péju E; Nielsen LB; Hvas CL; Dufranc E; Canet E; Lundqvist L; Wright CJ; Schmidt J; Uhel F; Ait-Oufella H; Krag M; Cos Badia E; Díaz-Lagares C; Menat S; Voiriot G; Clausen NE; Lorentzen K; Kvåle R; Hildebrandt T; Holten AR; Strand K; Tzalavras A; Bestle MH; Klepstad P; Fernandez S; Vimpere D; Paulino C; Graça C; Lueck C; Juhl CS; Costa C; Bådstøløkken PM; Miranda T; Lêdo LSA; Sousa Torres JC; Granholm A; Møller MH; Russell L;
    Intensive Care Med; 2023 Nov; 49(11):1327-1338. PubMed ID: 37812225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.